Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARCT Arcturus Therapeutics Ltd.

交易中 02-06 11:21:22 EST

7.23

+0.21

+2.92%

最高7.35	最低7.01	成交量12.81万
今开7.24	昨收7.02	日振幅4.77%
总市值2.05亿	流通市值1.90亿	总股本2,841万
成交额91.48万	换手率0.49%	流通股本2,628万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":7.225,"timestamp":1770394876167,"preClose":7.02,"halted":0,"volume":128074,"delay":0,"changeRate":0.029202279202279215,"floatShares":26275300,"shares":28412537,"eps":-2.46113,"marketStatus":"交易中","change":0.205,"latestTime":"02-06 11:21:22 EST","open":7.24,"high":7.345,"low":7.01,"amount":914816.1885279999,"amplitude":0.047721,"askPrice":7.25,"askSize":68,"bidPrice":7.21,"bidSize":75,"shortable":3,"etf":0,"ttmEps":-2.46113,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.02,"preHourTrading":{"tag":"盘前","latestPrice":7.3,"preClose":7.02,"latestTime":"09:13 EST","volume":2619,"amount":18391.1095863,"timestamp":1770387228372,"change":0.28,"changeRate":0.039886,"amplitude":0.045584},"postHourTrading":{"tag":"盘后","latestPrice":7,"preClose":7.02,"latestTime":"19:47 EST","volume":16060,"amount":112591.9646,"timestamp":1770338847867,"change":-0.02,"changeRate":-0.002849,"amplitude":0.01567},"volumeRatio":0.891894,"impliedVol":1.346,"impliedVolPercentile":0.8127},"requestUrl":"/m/hq/s/ARCT/tweets","defaultTab":"tweets","newsList":[{"id":"1173114596","title":"英国MHRA批准Zapomeran（Kostaive）mRNA新冠疫苗用于18岁及以上人群免疫接种","url":"https://stock-news.laohu8.com/highlight/detail?id=1173114596","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173114596?lang=zh_cn&edition=full","pubTime":"2026-01-02 21:41","pubTimestamp":1767361267,"startTime":"0","endTime":"0","summary":"英国药品和保健品监管局已正式批准ZapomeranmRNA新冠疫苗的紧急使用授权，该疫苗获准用于18岁及以上成年人群的主动免疫接种。此次批准标志着基于mRNA技术的新冠疫苗阵营再添重要力量，为应对持续演变的疫情提供了新的防控工具。作为由Arcturus Therapeutics Ltd.研发的创新型疫苗，Zapomeran采用自扩增mRNA技术平台，具有单剂接种可能诱发强效免疫应答的潜力。此次获批将扩大英国疫苗接种计划的可选范围，为不同健康需求的成年人群提供更多免疫策略选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"1177153636","title":"Arcturus Therapeutics将在2025年11月10日发布第三季度财务结果并提供公司更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1177153636","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177153636?lang=zh_cn&edition=full","pubTime":"2025-10-29 04:02","pubTimestamp":1761681739,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics将在2025年11月10日发布第三季度财务结果并提供公司更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"1126056048","title":"Arcturus Therapeutics 股价下跌 56.6%，囊性纤维化药物初步分析未见改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1126056048","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126056048?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:39","pubTimestamp":1761140348,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics 股价下跌 56.6%，囊性纤维化药物初步分析未见改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"1160945724","title":"Arcturus Therapeutics 股价在盘前暴跌52.6%，因吸入型mRNA治疗囊性纤维化的中期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1160945724","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160945724?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:39","pubTimestamp":1761133158,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics 股价在盘前暴跌52.6%，因吸入型mRNA治疗囊性纤维化的中期试验结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"gpt_icon":0},{"id":"1140271252","title":"Arcturus Therapeutics Ltd. - Arct-032在I级囊性纤维化参与者中显示粘液栓块减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1140271252","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140271252?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:31","pubTimestamp":1761132672,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Ltd. - Arct-032在I级囊性纤维化参与者中显示粘液栓块减少","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"1122274269","title":"生物制药概念股普涨， APLT暴涨24%，LRMR涨16%，阿斯利康涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122274269","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122274269?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:15","pubTimestamp":1759328132,"startTime":"0","endTime":"0","summary":"再生元制药公司涨6.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3953510fd7eeb47ed4578bf140220b88","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLT","AZN","LRMR","ARCT"],"gpt_icon":0},{"id":"2567190639","title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190639","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190639?lang=zh_cn&edition=full","pubTime":"2025-09-13 06:38","pubTimestamp":1757716705,"startTime":"0","endTime":"0","summary":"研发新冠疫苗的BioNTech盘中跌超10%、莫德纳跌超7%、Novavax跌超4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。更新中","market":"us","thumbnail":"https://static.tigerbbs.com/632b4e916ff966270173f4303843021f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/632b4e916ff966270173f4303843021f"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3755508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3755508","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["PGEN","AZN","BK4009","NVAX","KALV","TARS","NVS","PFE","MRNA","BNTX","STRO","PSNL","ABUS","MRK","ARCT","TVTX","SRPT","BMY","TRVI"],"gpt_icon":1},{"id":"1178671000","title":"Arcturus Therapeutics Ltd. - Meiji Seika Pharma公司的Kostaive mRNA疫苗在日本获得批准 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1178671000","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178671000?lang=zh_cn&edition=full","pubTime":"2025-08-29 18:12","pubTimestamp":1756462349,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Ltd. - Meiji Seika Pharma公司的Kostaive mRNA疫苗在日本获得批准 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"2518830278","title":"Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518830278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518830278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615845,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价急速跳水5.39%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3224.22%、699.68%、373.76%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2518028165","title":"Arcturus Therapeutics Holdings Inc.2024财年实现净利润-80.94百万美元，同比减少172.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518028165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518028165?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536075,"startTime":"0","endTime":"0","summary":"3月10日，Arcturus Therapeutics Holdings Inc.公布财报，公告显示公司2024财年净利润为-80.94百万美元，同比减少172.25%；其中营业收入为1.38亿美元，同比减少12.66%，每股基本收益为-3.00美元。机构评级：截至2025年3月10日，当前有8家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测，其中目标均价为72.62美元，其中最低目标价为48.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2517456003","title":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456003","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517456003?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:52","pubTimestamp":1741369931,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08015248604974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"1138230349","title":"Arcturus Therapeutics 2024年第四季度GAAP每股收益$(1.11)，不及预期$(0.44)，销售额$22.800M，不及预期$44.650M","url":"https://stock-news.laohu8.com/highlight/detail?id=1138230349","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138230349?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:07","pubTimestamp":1741295246,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics报告季度亏损每股$，比分析师的共识预期$低152.27%。这一数据比去年同期的每股亏损$减少了246.88%。公司报告季度销售额为$22.800M，比分析师的共识预期$44.650M低48.94%。以上内容来自Benzinga Earnings专栏，原文如下：Arcturus $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 152.27 percent. This is a 246.88 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $22.800 million which missed the analyst consensus estimate of $44.650 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ARCT"],"gpt_icon":0},{"id":"2516540726","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516540726?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:34","pubTimestamp":1741026893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时34分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速跳水5.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4398.57%、193.95%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2516230136","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘大幅拉升5.04%报16.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516230136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516230136?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:51","pubTimestamp":1740775870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时51分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.04%。截至发稿，该股报16.87美元/股，成交量22.9722万股，换手率0.85%，振幅9.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"gpt_icon":0},{"id":"2513727043","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速下挫5.35%报16.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727043?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:53","pubTimestamp":1740408797,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时53分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速下跌5.35%。截至发稿，该股报16.82美元/股，成交量3.1745万股，换手率0.12%，振幅4.67%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2513212905","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513212905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513212905?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:33","pubTimestamp":1740169995,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时33分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.02%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为325.39%、253.55%、138.64%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222043316abd7f908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222043316abd7f908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2512354165","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512354165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512354165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889501,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价快速上涨5.48%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为295.96%、102.57%、80.14%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.79%、23.16%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238229889fe50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238229889fe50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2511369691","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.42%报17.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511369691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511369691?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:34","pubTimestamp":1739543671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时34分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价大幅上涨5.42%。截至发稿，该股报17.30美元/股，成交量4.4872万股，换手率0.17%，振幅2.44%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223431a24601c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223431a24601c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2509723826","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509723826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509723826?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:17","pubTimestamp":1738768643,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时17分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.86%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3901.41%、1139.89%、671.38%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231723abc387cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231723abc387cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2508364149","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.07%报16.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508364149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508364149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593403,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价大幅下挫5.07%。截至发稿，该股报16.11美元/股，成交量1.7307万股，换手率0.06%，振幅2.57%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236439616fc7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236439616fc7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":-0.0727},{"period":"1month","weight":0.062},{"period":"3month","weight":-0.195},{"period":"6month","weight":-0.4106},{"period":"1year","weight":-0.6085},{"period":"ytd","weight":0.1452}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcturus Therapeutics Holdings Inc.在以色列注册，并于2008年2月7日开始运营。该公司是一家全球信使RNA药物公司，专注于开发针对肝脏和呼吸道罕见病的传染病疫苗和疗法。该公司正在利用专有的LUNAR平台和核酸技术，开发和推进一系列基于mRNA的疫苗和疗法，用于有重大未满足医疗需求的传染病和罕见遗传疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.084619},{"month":2,"riseRate":0.461538,"avgChangeRate":0.004443},{"month":3,"riseRate":0.25,"avgChangeRate":-0.05017},{"month":4,"riseRate":0.583333,"avgChangeRate":0.110815},{"month":5,"riseRate":0.583333,"avgChangeRate":0.094979},{"month":6,"riseRate":0.615385,"avgChangeRate":0.024246},{"month":7,"riseRate":0.538462,"avgChangeRate":0.096382},{"month":8,"riseRate":0.538462,"avgChangeRate":0.072518},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052457},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.064746}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}